IL139588A0 - Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone - Google Patents

Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Info

Publication number: IL139588A0
Authority: IL; Israel
Prior art keywords: teerapeutic; combinations; estrogen receptor; parathyroid hormone; receptor modulator
Prior art date: 1998-06-16

Application number

IL13958899A

Other languages

English (en)

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

1999-05-26

Publication date

2002-02-10

1999-05-26 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2002-02-10 Publication of IL139588A0 publication Critical patent/IL139588A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)

IL13958899A 1998-06-16 1999-05-26 Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone IL139588A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8947998P	1998-06-16	1998-06-16
PCT/IB1999/000949 WO1999065482A1 (en)	1998-06-16	1999-05-26	Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Publications (1)

Publication Number	Publication Date
IL139588A0 true IL139588A0 (en)	2002-02-10

Family

ID=22217879

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13958899A IL139588A0 (en)	1998-06-16	1999-05-26	Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone

Country Status (34)

Country	Link
US (1)	US6132774A (xx)
EP (1)	EP1094808A1 (xx)
JP (1)	JP2002518323A (xx)
KR (1)	KR20010052818A (xx)
CN (1)	CN1305373A (xx)
AP (1)	AP9901580A0 (xx)
AR (1)	AR018867A1 (xx)
AU (1)	AU3725999A (xx)
BG (1)	BG105125A (xx)
BR (1)	BR9911228A (xx)
CA (1)	CA2335078A1 (xx)
CO (1)	CO5070584A1 (xx)
EA (1)	EA200001199A1 (xx)
GT (1)	GT199900066A (xx)
HN (1)	HN1999000063A (xx)
HR (1)	HRP20000858A2 (xx)
HU (1)	HUP0102759A3 (xx)
ID (1)	ID26873A (xx)
IL (1)	IL139588A0 (xx)
IS (1)	IS5719A (xx)
MA (1)	MA26649A1 (xx)
NO (1)	NO20006313L (xx)
NZ (1)	NZ508039A (xx)
OA (1)	OA11566A (xx)
PA (1)	PA8471201A1 (xx)
PE (1)	PE20000644A1 (xx)
PL (1)	PL344982A1 (xx)
SK (1)	SK18922000A3 (xx)
TN (1)	TNSN99119A1 (xx)
TR (1)	TR200003567T2 (xx)
UA (1)	UA60367C2 (xx)
WO (1)	WO1999065482A1 (xx)
YU (1)	YU75800A (xx)
ZA (1)	ZA993972B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US20020107230A1 (en) *	2000-12-22	2002-08-08	Waldon R. Forrest	Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) *	2002-04-03	2003-10-09	Leonard Thomas W.	Method of hormonal therapy
BRPI0416639A (pt)	2003-11-19	2007-01-16	Metabasis Therapeutics Inc	tiromiméticos contendo fósforo
EP1819681B1 (en) *	2004-11-23	2009-08-12	Warner-Lambert Company LLC	7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7790745B2 (en)	2005-10-21	2010-09-07	Bristol-Myers Squibb Company	Tetrahydroisoquinoline LXR Modulators
US7919506B2 (en)	2006-03-10	2011-04-05	Pfizer Inc.	Dibenzyl amine compounds and derivatives
CN101663262B (zh)	2006-12-01	2014-03-26	百时美施贵宝公司	用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US20120046364A1 (en)	2009-02-10	2012-02-23	Metabasis Therapeutics, Inc.	Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
TW201043595A (en) *	2009-03-13	2010-12-16	Organon Nv	Tetrahydronaphthalen-2-ol derivatives
DE102010027016A1 (de)	2010-07-09	2012-01-12	Universitätsklinikum Jena	Steroid-Styrylfarbstoff-Konjugate zur Simulation und direkten lichtoptischen Detektion des Verhaltens von Steroiden im lebenden biologischen Gewebe und in Gegenwart von steroidbindenden Proteinen
CN111067907A (zh) *	2018-10-18	2020-04-28	常州大学	孕激素在抑制血管内皮生长因子表达中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5254595A (en) *	1988-12-23	1993-10-19	Elf Sanofi	Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
US5552412A (en) *	1995-01-09	1996-09-03	Pfizer Inc	5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
TW432073B (en) *	1995-12-28	2001-05-01	Pfizer	Pyrazolopyridine compounds
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis

1999
- 1999-04-29 PA PA19998471201A patent/PA8471201A1/es unknown
- 1999-05-03 HN HN1999000063A patent/HN1999000063A/es unknown
- 1999-05-10 GT GT199900066A patent/GT199900066A/es unknown
- 1999-05-26 US US09/424,010 patent/US6132774A/en not_active Expired - Fee Related
- 1999-05-26 HR HR20000858A patent/HRP20000858A2/hr not_active Application Discontinuation
- 1999-05-26 PL PL99344982A patent/PL344982A1/xx unknown
- 1999-05-26 AU AU37259/99A patent/AU3725999A/en not_active Abandoned
- 1999-05-26 UA UA2000127244A patent/UA60367C2/uk unknown
- 1999-05-26 YU YU75800A patent/YU75800A/sh unknown
- 1999-05-26 CA CA002335078A patent/CA2335078A1/en not_active Abandoned
- 1999-05-26 ID IDW20002626A patent/ID26873A/id unknown
- 1999-05-26 HU HU0102759A patent/HUP0102759A3/hu unknown
- 1999-05-26 OA OA1200000340A patent/OA11566A/en unknown
- 1999-05-26 BR BR9911228-0A patent/BR9911228A/pt not_active IP Right Cessation
- 1999-05-26 IL IL13958899A patent/IL139588A0/xx unknown
- 1999-05-26 SK SK1892-2000A patent/SK18922000A3/sk unknown
- 1999-05-26 EA EA200001199A patent/EA200001199A1/ru unknown
- 1999-05-26 TR TR2000/03567T patent/TR200003567T2/xx unknown
- 1999-05-26 EP EP99919491A patent/EP1094808A1/en not_active Withdrawn
- 1999-05-26 WO PCT/IB1999/000949 patent/WO1999065482A1/en not_active Ceased
- 1999-05-26 JP JP2000554362A patent/JP2002518323A/ja active Pending
- 1999-05-26 CN CN99807345A patent/CN1305373A/zh active Pending
- 1999-05-26 KR KR1020007014141A patent/KR20010052818A/ko not_active Ceased
- 1999-05-26 NZ NZ508039A patent/NZ508039A/xx unknown
- 1999-06-10 AP APAP/P/1999/001580A patent/AP9901580A0/en unknown
- 1999-06-14 PE PE1999000526A patent/PE20000644A1/es not_active Application Discontinuation
- 1999-06-15 TN TNTNSN99119A patent/TNSN99119A1/fr unknown
- 1999-06-15 AR ARP990102846A patent/AR018867A1/es not_active Application Discontinuation
- 1999-06-15 ZA ZA9903972A patent/ZA993972B/xx unknown
- 1999-06-15 MA MA25623A patent/MA26649A1/fr unknown
- 1999-06-16 CO CO99037623A patent/CO5070584A1/es unknown
2000
- 2000-11-21 IS IS5719A patent/IS5719A/is unknown
- 2000-12-12 NO NO20006313A patent/NO20006313L/no not_active Application Discontinuation
2001
- 2001-01-08 BG BG105125A patent/BG105125A/xx unknown

Also Published As

Publication number	Publication date
ZA993972B (en)	2000-12-15
PL344982A1 (en)	2001-11-19
UA60367C2 (uk)	2003-10-15
PE20000644A1 (es)	2000-08-02
EP1094808A1 (en)	2001-05-02
PA8471201A1 (es)	2000-09-29
BG105125A (en)	2001-11-30
AR018867A1 (es)	2001-12-12
AU3725999A (en)	2000-01-05
MA26649A1 (fr)	2004-12-20
WO1999065482A1 (en)	1999-12-23
YU75800A (sh)	2003-12-31
JP2002518323A (ja)	2002-06-25
HUP0102759A2 (hu)	2002-03-28
IS5719A (is)	2000-11-21
OA11566A (en)	2004-05-26
HUP0102759A3 (en)	2002-12-28
GT199900066A (es)	2000-10-31
TNSN99119A1 (fr)	2005-11-10
BR9911228A (pt)	2001-02-13
HRP20000858A2 (en)	2001-10-31
CO5070584A1 (es)	2001-08-28
EA200001199A1 (ru)	2001-04-23
SK18922000A3 (sk)	2001-09-11
NZ508039A (en)	2003-03-28
CA2335078A1 (en)	1999-12-23
TR200003567T2 (tr)	2001-06-21
AP9901580A0 (en)	1999-06-30
CN1305373A (zh)	2001-07-25
NO20006313D0 (no)	2000-12-12
HN1999000063A (es)	2000-01-12
US6132774A (en)	2000-10-17
NO20006313L (no)	2000-12-12
ID26873A (id)	2001-02-15
KR20010052818A (ko)	2001-06-25

Publication	Publication Date	Title
IL185087A0 (en)	2007-12-03	Selective estrogen receptor modulator in combination with a sex steroid precursor
GB9800854D0 (en)	1998-03-11	A material and device for terminal transaction
IL137035A0 (en)	2001-06-14	Method and device for configuring a link
IL149990A0 (en)	2002-12-01	Selective estrogen receptor modulators in combination with estrogens
IL147485A0 (en)	2002-08-14	Pharmaceutical compositions containing a selective estrogen receptor modulator
HUP0100485A3 (en)	2001-07-30	Device for linking and connecting a line
IL139588A0 (en)	2002-02-10	Teerapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
GB9907893D0 (en)	1999-06-02	System,device,and method for scheduling in a communication system
GB2332796B (en)	2001-11-14	A mixer for a receiver
GB9828537D0 (en)	1999-02-17	A radio device
IL136457A0 (en)	2001-06-14	System and procedure for directing a short message
GB2329098B (en)	1999-12-22	A mixing and dispensing apparatus
GB9715250D0 (en)	1997-09-24	A material and device for terminal printing
GB2346100B (en)	2000-12-06	Device for arresting a shaft
HUP0002779A3 (en)	2003-01-28	Method for transferring a bi-directional radio link and corresponding device
GB9718820D0 (en)	1997-11-12	A pointing device
HUP0103436A3 (en)	2002-02-28	Method and device for automatically switching a mortar gun on and off
GB9727321D0 (en)	1998-02-25	A mixer
TW337728U (en)	1998-08-01	A transverse mixer system
HK1032007A (en)	2001-07-06	Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
GB9815888D0 (en)	1998-09-16	A modulator
GB9806032D0 (en)	1998-05-20	Estrogen receptor
EP1214342A4 (en)	2003-02-26	POLYNECLUOTIDES, POLYPEPTIDES AND ANTIBODIES OF STEROID HORMONE RECEPTORS
GB9705765D0 (en)	1997-05-07	A location device and a method using same
ZA9811639B (en)	1999-06-24	A dosing device